BPA Call 36E79720A0008-36C26321N0978
Award Date
8/25/21
Potential Completion Date
8/24/22
Potential Value
$128K
Federal Agency
Veterans Integrated Service Network 23
Awardee
United Therapeutics Corp
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $14,693.62 firm-fixed-price delivery order to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods, for the TYVASO 0.6 REFILL KIT. This delivery order is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics has two significant Indefinite Delivery Vehicles (IDVs) with the VA, including a $50 million Blanket...
This is a $75,656.34 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for a 6-month supply of Tyvaso (treprostinil) 0.6mg/mL inhalation solution refill kits. This delivery order is placed against United Therapeutics' $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for the supply of its...
This firm fixed-price federal contract was awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $110,261.60 contract was issued as a Blanket Purchase Agreement (BPA) call against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract provides specialized pulmonary arterial hypertension and cancer treatment...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract, a delivery order valued at $14,989.01, is for the provision of TYVASO 0.6 REFILL KIT, a specialized medication used to treat pulmonary arterial hypertension. The contract was awarded against United Therapeutics' existing Federal Supply Schedule (FSS) contract...
This federal contract award is for the procurement of TYVASO, a pharmaceutical product developed and manufactured by United Therapeutics Corp, a self-certified small disadvantaged business. The contract, worth $13,050.45, was awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs (VA), to United Therapeutics as the prime contractor. This is a firm fixed-price Blanket Purchase Agreement (BPA) call order placed against United...
This is a federal contract award issued by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $89,973.91, is a Blanket Purchase Agreement (BPA) call order for the drug Tyvaso (treprostinil) 0.6 mg/mL solution refill kits. The contract is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, and does not...
The U.S. Department of Veterans Affairs (VA) awarded a $31,959.14 firm fixed price delivery order to United Therapeutics Corp, a small disadvantaged business, for the provision of the Tyvaso inhalation solution. This delivery order is placed against United Therapeutics' $198 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, which was issued by the VA in 2020. United Therapeutics also holds a $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition...
This federal contract award is for the delivery of TYVASO 0.6 REFILL KIT to the U.S. Department of Veterans Affairs (VA) by United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $14,989.01 firm-fixed-price delivery order was placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs and has an ultimate completion date of March 21, 2025. United Therapeutics holds two significant...
This federal contract award is for the delivery of Tyvaso 0.6 Refill Kits to the U.S. Department of Veterans Affairs (VA). The contract was awarded to United Therapeutics Corporation, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract is a delivery order with a firm-fixed price of $14,989.01 and a completion date of February 10, 2025. The contract is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for...
This federal contract award is for the delivery of the drug Tyvaso to the U.S. Department of Veterans Affairs (VA). The prime contractor is United Therapeutics Corp, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract has a ceiling value of $151,408.29 and is a firm-fixed-price delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract supports the VA's mission...